Status:
COMPLETED
Repetitive Transcranial Magnetic Stimulation (rTMS) and P50 Evoked Potential Component
Lead Sponsor:
University Hospital, Caen
Conditions:
Depression
Schizophrenia
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
Brief Summary
The repetitive transcranial magnetic stimulation (rTMS) is a recent technique that has demonstrated its efficiency in both depression and schizophrenia. However if its efficiency has been recognized b...
Eligibility Criteria
Inclusion
- healthy subjects, right-handed, aged from 18 to 60 years
- written consent
- with social security
Exclusion
- pregnancy, breastfeeding
- brain tumor or epilepsy
- psychiatric, neurological or ear-nose-throat disorders, current or past
- healthy subjects with psychotropic drugs or with substance abuses
- healthy subjects with tabacco weaning
- protected major with tutor
- counter-indication to MRI and rTMS
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01466439
Start Date
May 1 2011
End Date
June 1 2013
Last Update
June 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Caen University Hospital, department of psychiatry and explorations fonctionnelles neurologiques
Caen, France